Skip to content

To compare the pain relief by adding clonidine to suprazygomatic maxillary nerve blocks for pediatric cleft lip and palate surgeries

A randomized controlled trial to assess the efficacy of clonidine as an adjunct to suprazygomatic maxillary nerve blocks for pediatric cleft lip and palate surgeries. - NIL

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/12/098597
Enrollment
60
Registered
2025-12-08
Start date
Unknown
Completion date
Unknown
Last updated
2026-01-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: P968- Other specified conditions originating in the perinatal period Health Condition 2: Q379- Unspecified cleft palate with unilateral cleft lip

Interventions

Intervention1: Bilateral suprazygomatic maxillary nerve block with additve (single shot): Bilateral suprazygomatic maxillary nerve block using 0.25% levobupivacaine (0.15 mL/kg per side) and clonidine

Sponsors

Childrens Anaesthesia Services Mumbai
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: ASA 1/2 with Cleft palate and/lip

Exclusion criteria

Exclusion criteria: ASA 3 /4 with other malformations

Design outcomes

Primary

MeasureTime frame
To get the percentage of patients requiring supplemental analgesia (rescue dose) within 4 hours postoperatively using the FLACC score.Timepoint: 4 hours

Secondary

MeasureTime frame
Pain scores 0-24 h (Pain scale (FLACC), food intake during 12-24 hours postop, Duration of sleep5, and sedation scores during postop period, complications like POV, bradycardia, emergence delirium etc., Length of hospital stay (24 hours to 48 hours or more), Wound healing on the 5 th day: A: excellent. b: satisfatctory. c: Poor.Timepoint: 24 hours

Countries

India

Contacts

Public ContactDr Vrushali C Ponde

Holy Spirit Hospital, Mumbai

vrushaliponde@yahoo.co.in09819886502

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026